Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Fernando Tatsch"'
Autor:
Luis Viola, Sebastian Marciano, Luis Colombato, Henrique Coelho, Hugo Cheinquer, Gabriela Bugarin, Fernando Tatsch, Roberto J. Carvalho-Filho, Juan P. Roblero, Adriana Varon, Jaime Holguin, Maria R. Torres-Ibarra, Alma M. Pérez-Ríos
Publikováno v:
Annals of Hepatology, Vol 19, Iss 2, Pp 161-165 (2020)
Introduction and objectives: Currently, there are limited data on the epidemiology and disease characteristics of patients with chronic hepatitis C (CHC) in Latin America. The primary objective of this study was to evaluate demographic and disease ch
Externí odkaz:
https://doaj.org/article/d361bbc0f3c2477e84d970c3fc57db37
Autor:
Mario G. Pessôa, Hugo Cheinquer, Paulo R.L. Almeida, Giovanni F. Silva, Maria Patelli J.S. Lima, Raymundo Paraná, Marco A. Lacerda, Edison R. Parise, José R.B. Pernambuco, Suelene S. Pedrosa, Rosângela Teixeira, Hoel Sette, Jr, Fernando Tatsch
Publikováno v:
Annals of Hepatology, Vol 11, Iss 1, Pp 52-61 (2012)
Introduction. A large number of patients with chronic hepatitis C have not been cured with interferon-based therapy. Therefore, we evaluated the efficacy of amantadine combined with the standard of care (pegylated interferon plus ribavirin) in patien
Externí odkaz:
https://doaj.org/article/cb9c25b8cf664fe586ab76e36c2da4f2
Autor:
Delvone Almeida, José Tavares-Neto, Marcony Queiroz-Andrade, Camila Dias, Terezinha Ribeiro, Francisco Silva, Jailson Silva-Araújo, Fernando Tatsch, Raymundo Paraná
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical, Vol 39, Iss 1, Pp 76-78 (2006)
No Povoado de Cavunge, semi-árido da Bahia, foi realizado estudo sobre as hepatites com objetivo de avaliar a prevalência de portadores de IgG anti-VHA. Foram avaliados 891 moradores e 85,9% foram soropositivos. A prevalência foi semelhante entre
Externí odkaz:
https://doaj.org/article/55efbf3564df4b99935f1e871830dc04
Autor:
Rekha Badiger, Jane A Mitchell, Hime Gashaw, Neil A Galloway-Phillipps, Stefan Foser, Fernando Tatsch, Thomas Singer, Trevor T Hansel, Tobias Manigold
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e46779 (2012)
Alfa-interferons (IFNα2a, IFNα2b, 40KDa-PEGIFNα2a and 12KDa-PEGIFNα2b) are effective treatments for chronic hepatitis C infection. However, their usage has been associated with a variety of adverse events, including interstitial pneumonitis and p
Externí odkaz:
https://doaj.org/article/8b3d9158413b4a5190c0cfc5b2c0d180
Autor:
François D’heygere, Christophe George, François Habersetzer, Davender Tripathi, Calvin Q. Pan, Jose A. Giron, Manuela Schmitz, Fernando Tatsch
Publikováno v:
Annals of Hepatology, Vol 13, Iss 2, Pp 303-304 (2014)
Externí odkaz:
https://doaj.org/article/1e07361d72064f8191ba3735c509fd4a
Autor:
Delvone Almeida, José Tavares-Neto, Ludmila Vitvitski, Alessandro Almeida, Caroline Mello, Diana Santana, Fernando Tatsch, Raymundo Paraná
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 10, Iss 5, Pp 317-321
In the village of Cavunge, located in a dry tropical, semiarid rural region of the state of Bahia, Brazil, a sentinel study on viral hepatitis is underway. We report on the first part of the study. The objective of this study was to determine the pre
Externí odkaz:
https://doaj.org/article/3e409e58bdac40159c9cdf17396919af
Autor:
Qinglu Cheng, Evan B. Cunningham, Sophy Shih, Janaki Amin, Julie Bruneau, Adelina A. Artenie, Jeff Powis, Alain H. Litwin, Curtis Cooper, Olav Dalgard, Margaret Hellard, Philip Bruggmann, Philippa Marks, Karine Lacombe, Catherine Stedman, Phillip Read, Behzad Hajarizadeh, Adrian J. Dunlop, Brian Conway, Jordan J. Feld, Gregory J. Dore, Jason Grebely, Gregory Dore, Sione Crawford, Tracy Swan, Jude Byrne, Melanie Lacalamita. Coordinating Centre—Amanda Erratt, Evan Cunningham, Pip Marks, Ineke Shaw, Sharmila Siriragavan, Sophie Quiene, Kathy Petoumenos, Patrick Schmid, Erika Castro, Alberto Moriggia, Jean-Pierre Daulouede, Christopher Fraser, Jordan Feld, Ed Gane, Gail Matthews, Adrian Dunlop, Ian Kronborg, David Shaw, Alain Litwin, Brianna Norton, Maria Christine Thurnheer, Martin Weltman, Philip Read, John Dillon, Simone Kessler, Cornelia Knapp, Lorenza Oprandi, Paola Messina, Marzia Pantic, Manuela Le Cam, Cecilia Maitre, Jessica Andreassen, Ingunn Melkeraaen, Merete Moen Tollefsen, Hannah Pagarigan, Rozalyn Milne, Kate Mason, Diana Kaznowski, Lily Zou, Rachel Bouchard, Barbara Kotsoros, Miriam Muir, Jessica Milloy, Victoria Oliver, Tracy Noonan, Alison Sevehon, Susan Hazelwood, Michelle Hall, Michelle Hagenauer, Rachel Liddle, Catherine Ferguson, Linda Agyemang, Hiral Patel, Irene Soloway, Orlando Cerocchi, Melanie Lacalamita, Vincenzo Fragomeli, Rosie Gilliver, Rebecca Lothian, Shirley Cleary, Linda Johnston, Sarah Middleton, Ronald D’Amico, Barbara McGovern, Jonathan Anderson, Ze Zhong, Fiona Keane, Fernando Tatsch, Diana Brainard, John McHutchison
Publikováno v:
Value in Health. 26:883-892
Autor:
Jordan J. Feld, Jinlin Hou, Kazuaki Chayama, Xavier Forns, Ashley Brown, Fernando Tatsch, Mark Bondin, Ira M. Jacobson, Stanislas Pol, John Marcinak, Amanda Emmett, Stuart C. Gordon, Jeong Heo, Zhenzhen Zhang, Pietro Lampertico, Margaret Burroughs, Douglas E. Dylla
Publikováno v:
Advances in Therapy
Introduction More than 70 million people are estimated to be infected with hepatitis C virus (HCV) globally. If left untreated, HCV infection can lead to complications such as extensive liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). E
Autor:
Jordan J. Feld, Xavier Forns, Douglas E. Dylla, Hiromitsu Kumada, Victor de Ledinghen, Lai Wei, Robert S. Brown, Robert Flisiak, Pietro Lampertico, Dominique Thabut, Mark Bondin, Fernando Tatsch, Margaret Burroughs, John Marcinak, Zhenzhen Zhang, Amanda Emmett, Ira M. Jacobson
Publikováno v:
Journal of viral hepatitisREFERENCES. 29(12)
Chronic hepatitis C virus (HCV) infection has the greatest health impact in patients with advanced liver disease. The direct-acting antiviral (DAA) regimen glecaprevir/pibrentasvir (G/P) is approved for treatment of HCV-infected patients without cirr
Autor:
Courtney DiNardo, Keith Pratz, Panayiotis Panayiotidis, Xudong Wei, Vladimir Vorobyev, Árpàd Illés, Inho Kim, Vladimir Ivanov, Grace Ku, Catherine Miller, Meng Zhang, Fernando Tatsch, Jalaja Potluri, Xenia Schmidt, Christian Recher
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S124